How to Change Your Mind

How to Change Your Mind
Name	How to Change Your Mind
Author	Michael Pollan
Country	United States
Language	English
Subject	Psychedelics, consciousness, psychotherapy
Publisher	Penguin Press
Pub date	2018
Pages	480
Isbn	9781594204227

How to Change Your Mind is a 2018 nonfiction book by Michael Pollan that examines the history, science, and therapeutic potential of psychedelic substances such as psilocybin, LSD, and MDMA through a mixture of reportage, history, and first-person experimentation. The work situates contemporary research within earlier mid‑20th century investigations by figures such as Albert Hofmann, Timothy Leary, and institutions like Johns Hopkins University and Harvard University, while exploring clinical trials, cultural backlash, and regulatory shifts involving agencies such as the Food and Drug Administration and the Drug Enforcement Administration. Pollan interweaves accounts of patients, scientists, and clinicians to argue that altered states can occasion profound shifts in belief, mood, and behavior.

Introduction

Pollan frames his inquiry by tracing psychedelic research from early chemistry and clinical trials led by Albert Hofmann and Humphry Osmond through the countercultural prominence of Timothy Leary and subsequent repression by the Nixon administration and the Controlled Substances Act. He synthesizes contributions from laboratories at Johns Hopkins University, Imperial College London, and New York University and interviews with researchers such as Roland Griffiths and Robin Carhart‑Harris. The introduction sets up questions about consciousness, psychotherapy, and regulatory science, while referencing clinical endpoints like treatment‑resistant depression studied in trials funded by entities including the Multidisciplinary Association for Psychedelic Studies.

Psychological Mechanisms of Belief Change

Pollan explores mechanisms by which psychedelics may alter beliefs, invoking theories advanced by researchers at Harvard University, Massachusetts Institute of Technology, and University College London. He summarizes the "default mode network" concept studied by teams led by Amitai Shenhav and David Eagleman and connects it to earlier neurophysiology from Santiago Ramón y Cajal and research traditions at the National Institutes of Health. The narrative references psychopharmacology work on serotonin receptors, notably 5‑HT2A sites characterized in pharmacology literature from Stanford University and Yale University, and integrates cognitive models from scholars at University of California, Berkeley and Princeton University. Through clinical case studies from centers like Johns Hopkins University and Mount Sinai Health System, Pollan illustrates how profound subjective experiences can reorganize narrative identity, a theme linked to psychologists such as William James and Carl Jung.

Strategies and Techniques for Changing One's Mind

The book outlines practical frameworks used in research protocols at Johns Hopkins University, Imperial College London, and clinics affiliated with New York University: careful screening as practiced at Massachusetts General Hospital, preparatory sessions modeled on psychotherapeutic approaches from Sigmund Freud's successors, guided sessions borrowing techniques from Carl Rogers and Aaron Beck, and integration work informed by community organizations like Psychedelic Science Funders Collaborative. Pollan documents dosing regimens that parallel clinical trials overseen by Food and Drug Administration investigators and therapeutic modalities that draw on existential psychotherapy as taught at Columbia University and University of Chicago. He also recounts practical hygiene from retreat centers patterned after practices at Esalen Institute and integration groups associated with MAPS.

Barriers and Cognitive Biases

Pollan addresses psychological and institutional barriers that impede belief change, referencing cognitive biases identified by researchers at Stanford University, Princeton University, and University of Pennsylvania, such as confirmation bias, motivated reasoning, and status quo bias. He situates sociopolitical impediments in the era of the War on Drugs under the Reagan administration and legal constraints enforced by the Drug Enforcement Administration. The narrative discusses scientific skepticism emanating from methodological critiques by scholars at Oxford University and University College London and notes how regulatory risk assessments at the Food and Drug Administration shape research trajectories. Individual barriers such as fear and defensive cognitive styles are illustrated through patient vignettes referencing clinicians trained at Johns Hopkins University and Yale School of Medicine.

Social and Cultural Influences

Pollan traces how cultural movements including the 1960s counterculture centered on figures like Ken Kesey and events such as the Summer of Love influenced public attitudes, and how academic institutions such as Harvard University and media outlets like The New Yorker have shaped discourse. He examines indigenous practices surrounding entheogens in regions like Mesoamerica and interactions with organizations like the Native American Church and highlights contemporary activism from groups including Decriminalize Nature and policy efforts in municipalities like Denver and Oakland, California. The book situates scientific revival within shifting funding landscapes involving private philanthropists and foundations such as those associated with Psychedelic Science Funders Collaborative.

Applications and Contexts

Pollan surveys clinical applications pursued at institutions including Johns Hopkins University, Massachusetts General Hospital, and Imperial College London, with focus areas like treatment‑resistant depression, end‑of‑life anxiety studied by Roland Griffiths, post‑traumatic stress disorder advanced by trials from Multidisciplinary Association for Psychedelic Studies and MAPS, and addiction research at centers influenced by pioneers from Mount Sinai. He discusses settings ranging from academic hospitals to retreat centers modeled after Esalen Institute and community clinics in jurisdictions experimenting with decriminalization such as Portland, Oregon.

Ethical Considerations

Pollan raises ethical questions about consent, therapeutic boundary issues, and cultural appropriation, citing debates in bioethics from scholars at Harvard Medical School, Georgetown University, and Oxford University. He addresses equity in access as healthcare systems in countries like United States and institutions such as National Health Service (United Kingdom) confront rollout decisions, and references policy deliberations involving regulators like the Food and Drug Administration and activist groups including Decriminalize Nature. The book prompts consideration of standards for clinical training promoted by professional bodies connected to American Psychiatric Association and ethical frameworks derived from histories involving Alan Watts and indigenous practitioners.

Category:Books about psychedelics